1 completed, 1 unknown. 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Spyridon Deftereos: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylactic Substrate Ablation in Post-myocardial Patients Undergoing Defibrillator Implantation. Ventricular tachycardia substrate ablation - Heart Failure, Myocardial Infarction | Not applicable | Unknown | Spyridon Deftereos | 40 | 2016-06-01 | 2016-05-24 |
| Moxonidine for Prevention of Post-ablation AFib Recurrences Moxonidine, Placebo - Atrial Fibrillation | Phase 4 | Completed | Spyridon Deftereos | 150 | 2012-08-01 | 2014-05-06 |
Atrial Fibrillation (1) · Heart Failure (1) · Myocardial Infarction (1) · Recurrence (1) · Tachycardia, Ventricular (1)
moxonidine (1)
Greece (1)
Charis Kossyvakis, MD (1) · Dimitris Tsiachris, MD (1) · George Giannopoulos, MD (1) · Spyros Deftereos, MD (1)